The Treatment of Lung Involvement in Systemic Sclerosis

The Treatment of Lung Involvement in Systemic Sclerosis

Systemic sclerosis (SSc) patients are often affected by interstitial lung disease (ILD) and, although there have been recent treatment advances, it remains the leading cause of death among SSc, with a 10-year mortality up to 40%. African Americans and subjects with diffuse cutaneous SSc or anti-topo...

Full description

Bibliographic Details
Main Authors: Barbara Ruaro, Marco Confalonieri, Marco Matucci-Cerinic, Francesco Salton, Paola Confalonieri, Mario Santagiuliana, Gloria Citton, Elisa Baratella, Cosimo Bruni
Format: Article
Language:English
Published: MDPI AG 2021-02-01
Series:Pharmaceuticals
Subjects:
systemic sclerosis
scleroderma
interstitial lung disease
pulmonary function tests
high-resolution computed tomography
Online Access:https://www.mdpi.com/1424-8247/14/2/154

Internet

https://www.mdpi.com/1424-8247/14/2/154

Similar Items